Christina Feser, DO
Dermatology · Clarksville, TNNPI 1902122096
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $312,105 of the $382,753 with a category attached, or 81.5%. Lilly USA, LLC accounts for 66.5% of it on its own, with 41 other manufacturers making up the rest. 2025 is the largest year on record at $135,978, more than ten times the $3,715 reported in 2019. Among dermatology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,454 payments — averaging $263.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$254K
- Galderma Laboratories, L.p.$42K
- Amgen$35K
- Incyte Corporation$10K
- Parapro, LLC$9K
- AbbVie$4K
- plus $29K from 36 others
Across 955 payments — averaging $3551.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$1.6M
- Eli Lilly$478K
- Amgen$328K
- Takeda Pharmaceuticals U.S.A., Inc.$281K
- AbbVie$249K
- Sanofi US Services Inc.$103K
- plus $350K from 8 others
What the payments were for
- Consulting fees$13,2033%
- Speaking & faculty fees$312,10582%
- Travel & lodging$22,2596%
- Food & beverage$34,3869%
- Education$8010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$382,753 in reported general payments places this provider in the 95th percentile of 209 dermatology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $50,656 |
| Clobetasol Propionate | 114 | $5,007 |
| Fluorouracil | 55 | $3,927 |
| Ketoconazole | 145 | $2,802 |
| Clindamycin Phosphate | 36 | $1,526 |
| Triamcinolone Acetonide | 126 | $1,347 |
| Metronidazole | 22 | $1,267 |
| Betamethasone Dipropionate | 34 | $1,178 |
| Doxycycline Hyclate | 50 | $962 |
| Fluocinonide | 11 | $652 |
| Calcipotriene | 13 | $621 |
| ValacyclovirValacyclovir Hcl | 23 | $574 |
| Mometasone Furoate | 41 | $572 |
| Hydrocortisone | 85 | $421 |
| Mupirocin | 41 | $308 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Clarksville
- Adam AllanClarksville$13K
- Kimberly LehmanClarksville$10K
- Kimberly VincentNashville$1.5M
- Adrian RodriguezNashville$1.1M
- Michael GoldNashville$748K
- Joni SagoKingsport$661K
- Jennifer LeeBrentwood$396K
- Emily OverholserMemphis$322K
- James TurnerBartlett$314K
- Kimberly GrandeKnoxville$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.